{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis+Multiple+Joint&page=13", "query": { "condition": "Arthritis Multiple Joint", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 344, "total_pages": 35, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis+Multiple+Joint&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis+Multiple+Joint&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T20:33:00.043Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04066712", "title": "Renal PK Study of LC350189", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gout", "Hyperuricemia" ], "interventions": [ { "name": "LC350189 200 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LG Chem", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 37, "start_date": "2019-11-19", "completion_date": "2020-09-12", "has_results": false, "last_update_posted_date": "2020-09-21", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04066712" }, { "nct_id": "NCT00071812", "title": "A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Belimumab 1 mg/kg", "type": "DRUG" }, { "name": "Belimumab 4 mg/kg", "type": "DRUG" }, { "name": "Belimumab 10 mg/kg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Human Genome Sciences Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 283, "start_date": "2003-12", "completion_date": "2005-12", "has_results": true, "last_update_posted_date": "2013-08-14", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Paradise Valley, Arizona • Tucson, Arizona + 53 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00071812" }, { "nct_id": "NCT00289081", "title": "Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee Prostheses", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis", "Arthritis, Rheumatoid", "Avascular Necrosis of Bone", "Post-traumatic Arthritis", "Rheumatoid Arthritis" ], "interventions": [ { "name": "Total knee replacement", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "DePuy Orthopaedics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 399, "start_date": "2001-02", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2014-05-13", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 4, "location_summary": "La Jolla, California • Crystal River, Florida • Melbourne, Florida + 1 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Crystal River", "state": "Florida" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Cleveland Heights", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00289081" }, { "nct_id": "NCT00663702", "title": "Phase IIIB Switching From Intravenous to Subcutaneous Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 123, "start_date": "2008-05", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2015-03-09", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 18, "location_summary": "Huntsville, Alabama • La Jolla, California • Long Beach, California + 15 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00663702" }, { "nct_id": "NCT05660772", "title": "Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Knee Osteoarthritis", "Osteo Arthritis Knee" ], "interventions": [ { "name": "Microfragmented Adipose Tissue", "type": "DEVICE" }, { "name": "Corticosteroid", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Lipogems International spa", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 173, "start_date": "2022-12-30", "completion_date": "2025-04-09", "has_results": false, "last_update_posted_date": "2025-04-22", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 18, "location_summary": "Encinitas, California • Redwood City, California • Gulf Breeze, Florida + 14 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Gulf Breeze", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Brookhaven", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05660772" }, { "nct_id": "NCT00509678", "title": "Rituxan With or Without Methotrexate in Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Swedish Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 6, "start_date": "2006-12", "completion_date": "2010-03", "has_results": false, "last_update_posted_date": "2012-01-18", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 4, "location_summary": "La Jolla, California • Stanford, California • Rochester, New York + 1 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Rochester", "state": "New York" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00509678" }, { "nct_id": "NCT05586971", "title": "Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gout", "Hyperuricemia", "Gout Flare", "Tophi" ], "interventions": [ { "name": "Tigulixostat", "type": "DRUG" }, { "name": "Allopurinol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LG Chem", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 2202, "start_date": "2023-03-30", "completion_date": "2025-05-06", "has_results": false, "last_update_posted_date": "2025-07-22", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 124, "location_summary": "Birmingham, Alabama • Daphne, Alabama • Mobile, Alabama + 91 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05586971" }, { "nct_id": "NCT04011488", "title": "Shared Decision Making and How It Impacts the Patient Understanding", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "Shared Decision Making Tool", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "64 Years", "sex": "FEMALE", "summary": "45 Years to 64 Years · Female only" }, "enrollment_count": 108, "start_date": "2016-06", "completion_date": "2019-06-30", "has_results": false, "last_update_posted_date": "2019-07-08", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04011488" }, { "nct_id": "NCT00160602", "title": "A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Certolizumab Pegol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 590, "start_date": "2005-06", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2020-12-01", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 17, "location_summary": "Montgomery, Alabama • Sun City West, Arizona • Palm Desert, California + 14 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Sun City West", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Santa Maria", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00160602" }, { "nct_id": "NCT01373151", "title": "Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "BMS-945429 Placebo", "type": "DRUG" }, { "name": "BMS-945429", "type": "BIOLOGICAL" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Methotrexate Placebo", "type": "DRUG" }, { "name": "Adalimumab Placebo", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "CSL Behring", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 418, "start_date": "2011-06", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2021-12-06", "last_synced_at": "2026-10-22T20:33:00.043Z", "location_count": 13, "location_summary": "Peoria, Arizona • San Diego, California • Trumbull, Connecticut + 10 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Trumbull", "state": "Connecticut" }, { "city": "Quincy", "state": "Illinois" }, { "city": "Rockford", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01373151" } ] }